AlphaLens
Research
财报Equal-weightTP $88.00005月14日 · Morgan Stanley

Hua Hong Semiconductor Ltd: 1Q26 results in line; underwhelming 2Q revenue outlook

中文EN⚠ quality lint: see notes

Hua Hong Semiconductor: 2Q Revenue Guidance Misses as Near-Term Pressures Overshadow Long-Term Fab 9B Build-Out

Core Conclusion

Maintain Equal-weight on Hua Hong Semiconductor (1347.HK) with a HK$88 target price, implying 31% downside from the current HK$127. The 1Q26 results were in line with estimates, but the 2Q26 revenue guidance midpoint of US$695mn (up 5.1% QoQ) materially missed analyst expectations. The market is pricing in a recovery driven by AI infrastructure power IC demand, but the near-term evidence points to ongoing inventory digestion, pricing pressure, and a utilization-rate headwind that will delay margin expansion. At 69.2x 2026e P/E, the stock offers no margin of safety relative to fundamental earnings power.

What the Market May Be Underestimating

Near-term revenue weakness is worse than consensus expected. The 2Q26 revenue guidance of US$690-700mn implies roughly flat to slightly down sequential growth after adjusting for normal seasonality, and it came in below the covering analyst's estimate. The market appears to have extrapolated the positive AI infrastructure narrative too far into the near-term revenue trajectory. Inventory adjustments at customers and price competition in mature nodes are likely suppressing wafer shipments and blended ASPs more than anticipated.

The margin recovery timeline is pushed out. The 1Q26 gross margin of 13% missed estimates, reflecting slightly lower utilization. The 2Q26 guidance of 14-16% does represent sequential expansion on higher blended ASP, but achieving the upper end of that range is not guaranteed. More importantly, as Fab 9B adds 43kwpm capacity this year, the associated depreciation and operating costs will weigh on reported margins for at least 12-18 months before volume fill improves unit economics.

Evidence Chain

1Q26 revenue in line but gross margin missed. Revenue of US$661mn (+22% YoY, flat QoQ) matched both the analyst estimate and consensus. However, gross margin of 13% came in below the internal forecast due to a slightly lower-than-expected utilization rate. Net profit to shareholders of US$20.9mn missed the analyst estimate but beat consensus—indicating that non-operating items drove the beat, not core operations.

2Q26 revenue guidance midpoint 5.1% QoQ growth misses estimate. The company guided 2Q26 revenue of US$690-700mn. At the midpoint of US$695mn, this is below the covering analyst's estimate. The gross margin guidance of 14-16% implies meaningful sequential improvement, but this is heavily dependent on product mix shift toward higher-ASP wafers, which carries execution risk.

Fab 9B capacity expansion will dilute near-term returns. The analyst expects Hua Hong to add 43kwpm of new capacity at Fab 9B this year. The projected ROE trajectory of 6.1%/7.2%/8.3% for 2026-2028 is well below industry averages for mature-node foundries at similar stages. The combination of high capex, depreciation ramp, and gradual utilization fill will keep return on invested capital compressed.

Current valuation implies an unrealistic growth trajectory. At HK$127, the stock trades at 69.2x 2026e P/E, 55.7x 2027e P/E, and 45.5x 2028e P/E. The target price of HK$88, derived from a residual income model (9.2% cost of equity, 16.5% medium-term growth, 5.0% terminal growth), implies 31% downside. The valuation multiples are not supported by the projected ROE levels or the near-term demand environment.

Key Disagreements and Risks

Upside risks are narrow and execution-dependent. The bull case rests on faster-than-expected price hikes and utilization recovery. If local customers gain share rapidly and EV penetration accelerates, Hua Hong could see wafer ASPs and fab loading improve ahead of current forecasts. These outcomes would require both macro demand support and the company avoiding competitive displacement.

Downside risks are more numerous. The most immediate risk is that the potential price hike the market may be assuming does not materialize, leading to gross margins below the guided range. Other Chinese players are aggressively building 8-inch capacity, which could intensify pricing competition as supply catches up with demand. The ongoing application migration from 8-inch to 12-inch wafers structurally erodes the competitive position of Hua Hong's legacy 8-inch fabs over a multi-year horizon. Finally, Fab 9B could scale slower than expected or struggle to win new customers, leaving utilization and margins depressed for longer.

Valuation and Trading Implications

The HK$88 target price is based on a residual income model with a 9.2% cost of equity (2.0% risk-free rate, 6% equity risk premium, 1.20 beta), 16.5% medium-term growth, and 5.0% terminal growth. This yields 31% downside from the current HK$127.

Investors should wait for one of two catalysts before considering entry: (1) a 2Q26 earnings report that shows gross margin at or above the 16% upper end of guidance, signaling that pricing and utilization are inflecting, or (2) a material stock price correction that compresses the 2026e P/E multiple below 50x, creating a margin of safety against execution and demand risks. Until either condition is met, the risk/reward is unfavorable.

Appendix

Financial Forecast Summary (US$mn, except per-share data)

2025A2026E2027E2028E
Revenue2,4023,1173,4603,700
Gross Margin (%)13%14-16%16-18%17-19%
EBITDA6569951,1411,262
EPS (ModelWare, US$)0.030.230.290.36
ROE (%)0.96.17.28.3

Peer Valuation Comparison (2026e)

CompanyP/E (x)P/B (x)EV/EBITDA (x)ROE (%)
Hua Hong Semiconductor (1347.HK)69.24.030.76.1
SMIC (0981.HK)25.01.812.07.5
UMC (2303.TW)15.51.58.010.0
Vanguard Intl. Semiconductor (5347.TWO)18.01.99.510.5

Related (同 ticker)